SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Albert Einstein Synthetic CCD

PatientAlbert Einstein
Date of birth1956-03-14
IdentifiersMRN HR-ET012-SYN; SSN (made up) 000-12-6650
Document date2026-11-01
AuthorClementine Ward, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptoms. Concerns: An abdominal operation for episodes of abdominal pain found a large swelling of the main artery in his abdomen, which was wrapped rather than repaired; he wants to know its size, how it will be watched, and when an operation would be advised; He has smoked a pipe since his youth and is willing to try to stop; His blood pressure has stayed above target on one medicine. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2025-05-20activeS
Losartan 50 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2026-03-24 to 2026-04-21completedS
Losartan 100 mg oral tablet, one tablet dailyOne tablet by mouth each morningOral route2026-04-21activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet by mouth each eveningOral route2026-03-24activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet by mouth daily with foodOral route2026-04-21activeS
Nicotine 14 mg/24 hour transdermal patch, one patch dailyApply one new patch each morningTopical route2026-03-24 to 2026-07-14completedS
Nicotine 7 mg/24 hour transdermal patch, one patch dailyApply one new patch each morningTopical route2026-07-14 to 2026-09-22completedS
Nicotine 2 mg lozenge as needed for cravingsDissolve one lozenge in the mouth for a craving, no more often than every 2 hours and no more than 20 a dayOral route2026-03-24 to 2026-09-22completedS

Procedures

ProcedureDatesStatusEvidence
CT angiography of the abdominal aorta and iliac arteries: fusiform infrarenal aneurysm, maximum outer-wall diameter 5.2 cm, beginning 2.0 cm below the lowest renal artery and ending above the bifurcation; neck 2.2 cm wide with 30-degree angulation; moderate mural thrombus; calcified atheroma of the aorta and both common iliac arteries, which measure 1.3 cm; soft-tissue thickening along the front of the aneurysm consistent with the prior wrapping; no periaortic fluid; suprarenal aorta 2.4 cm2026-04-07 to 2026-04-07completedS
Smoking cessation counseling (5 A's), about 15 minutes, with a quit date and nicotine replacement2026-03-24 to 2026-03-24completedS

Immunizations

DateVaccineStatusEvidence
2025-10-07High-dose influenza vaccine, 2025-2026 seasoncompletedS
2026-08-25Pneumococcal conjugate vaccine PCV20completedS
2026-08-25Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1948Intermittent severe abdominal pain, at times with vomiting, worse toward the end of the yearD (CLM-0004)
December 31, 1948Exploratory laparotomy: a large abdominal aortic aneurysm was found; it could not be removed, and its front was wrapped in cellophane to provoke scarring; discharged about three weeks laterD (CLM-0005, CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
An abdominal operation for episodes of abdominal pain found a large swelling of the main artery in his abdomen, which was wrapped rather than repaired; he wants to know its size, how it will be watched, and when an operation would be advisedactiveS
He has smoked a pipe since his youth and is willing to try to stopactiveS
His blood pressure has stayed above target on one medicineactiveS

Assessment

Most recent measures: Aorta Diameter by US 5 on 2026-06-02; Hemoglobin [Mass/volume] in Blood 14.2 on 2026-03-24; Leukocytes [#/volume] in Blood by Automated count 7.4 on 2026-03-24; Platelets [#/volume] in Blood by Automated count 232 on 2026-03-24; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-07-14; Potassium [Moles/volume] in Serum or Plasma 4.7 on 2026-07-14; Creatinine [Mass/volume] in Serum or Plasma 1.1 on 2026-07-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 70 on 2026-07-14; Glucose [Mass/volume] in Serum or Plasma 98 on 2026-03-24; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-03-24; Cholesterol [Mass/volume] in Serum or Plasma 132 on 2026-07-14; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 2026-07-14; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 on 2026-07-14; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-07-14; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-03-24; Albumin/Creatinine [Mass Ratio] in Urine 14 on 2026-03-24; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-03-24; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-08-25; Total score [AUDIT-C] 1 on 2026-08-25 [S]

Strengths and supports: Supports: a settled household, close colleagues, daily walks, and absorbing work [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Infrarenal abdominal aortic aneurysm, 5.0 cm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy; under surveillance below the repair thresholdactiveconfirmed I71.43S — Synthetic modern coding anchored to the documented aneurysm found and wrapped at his exploratory laparotomy; the diameter and all surveillance are synthetic.
Essential hypertensionactiveconfirmed I10S — Synthetic risk factor in the modern frame; no historical blood pressure is documented in the cited sources.
Nicotine dependence, pipe tobaccoactiveconfirmed F17.290S — Synthetic modern coding anchored to his documented pipe smoking.
Atherosclerosis of the abdominal aorta, with calcified atheroma on CT angiographyactiveconfirmed I70.0S — Synthetic finding on the baseline CT angiography.
Acute low back strain after lifting, with aneurysm symptoms excluded; resolvedresolvedconfirmed S39.012AS — Synthetic intercurrent illness at an unscheduled visit, chosen to teach how new back pain is assessed in a patient with a known aneurysm. It does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-24Aorta Diameter by US5cm<=3 cmHighS
2026-03-24Hemoglobin [Mass/volume] in Blood14.2g/dL13.2-16.6 g/dLNormalS
2026-03-24Leukocytes [#/volume] in Blood by Automated count7.410*3/uL3.4-9.6 10*3/uLNormalS
2026-03-24Platelets [#/volume] in Blood by Automated count23210*3/uL135-317 10*3/uLNormalS
2026-03-24Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-03-24Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-03-24Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-03-24Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M77mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-24Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
2026-03-24Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-03-24Cholesterol [Mass/volume] in Serum or Plasma216mg/dL<=200 mg/dLHighS
2026-03-24Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-03-24Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation142mg/dL<=129 mg/dLHighS
2026-03-24Triglyceride [Mass/volume] in Serum or Plasma148mg/dL<=149 mg/dLNormalS
2026-03-24Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-03-24Albumin/Creatinine [Mass Ratio] in Urine14mg/g{creat}<=30 mg/g{creat}NormalS
2026-03-24Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-04-21Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-04-21Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-04-21Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.74-1.35 mg/dLNormalS
2026-04-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M72mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-14Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-07-14Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
2026-07-14Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-07-14Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M70mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-14Cholesterol [Mass/volume] in Serum or Plasma132mg/dL<=200 mg/dLNormalS
2026-07-14Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-07-14Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation62mg/dL<=129 mg/dLNormalS
2026-07-14Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
2026-09-22Aorta Diameter by US5.1cm<=3 cmHighS
2026-06-02Aorta Diameter by US5cm<=3 cmHighS
2026-08-25Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-08-25Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-24Body height172cmS
2026-03-24Body weight79kgS
2026-03-24Body mass index (BMI) [Ratio]26.7kg/m2S
2026-03-24Systolic blood pressure146mm[Hg]S
2026-03-24Diastolic blood pressure86mm[Hg]S
2026-03-24Heart rate72/minS
2026-03-24Respiratory rate14/minS
2026-03-24Body temperature36.7CelS
2026-03-24Oxygen saturation in Arterial blood by Pulse oximetry96%S
2026-04-21Body height172cmS
2026-04-21Body weight78.6kgS
2026-04-21Body mass index (BMI) [Ratio]26.6kg/m2S
2026-04-21Systolic blood pressure136mm[Hg]S
2026-04-21Diastolic blood pressure82mm[Hg]S
2026-04-21Heart rate70/minS
2026-04-21Respiratory rate14/minS
2026-04-21Body temperature36.6CelS
2026-04-21Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-07-14Body height172cmS
2026-07-14Body weight79.4kgS
2026-07-14Body mass index (BMI) [Ratio]26.8kg/m2S
2026-07-14Systolic blood pressure126mm[Hg]S
2026-07-14Diastolic blood pressure76mm[Hg]S
2026-07-14Heart rate68/minS
2026-07-14Respiratory rate14/minS
2026-07-14Body temperature36.6CelS
2026-07-14Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-22Body height172cmS
2026-09-22Body weight79.8kgS
2026-09-22Body mass index (BMI) [Ratio]27kg/m2S
2026-09-22Systolic blood pressure124mm[Hg]S
2026-09-22Diastolic blood pressure76mm[Hg]S
2026-09-22Heart rate66/minS
2026-09-22Respiratory rate14/minS
2026-09-22Body temperature36.6CelS
2026-09-22Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-06-02Body height172cmS
2026-06-02Body weight79.2kgS
2026-06-02Body mass index (BMI) [Ratio]26.8kg/m2S
2026-06-02Systolic blood pressure138mm[Hg]S
2026-06-02Diastolic blood pressure82mm[Hg]S
2026-06-02Heart rate76/minS
2026-06-02Respiratory rate16/minS
2026-06-02Body temperature36.7CelS
2026-06-02Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-08-25Body height172cmS
2026-08-25Body weight79.6kgS
2026-08-25Body mass index (BMI) [Ratio]26.9kg/m2S
2026-08-25Systolic blood pressure124mm[Hg]S
2026-08-25Diastolic blood pressure74mm[Hg]S
2026-08-25Heart rate66/minS
2026-08-25Respiratory rate14/minS
2026-08-25Body temperature36.6CelS
2026-08-25Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
2026-03-24Establishing care for a known abdominal aortic aneurysm: duplex ultrasound, blood pressure, lipids, smoking, and emergency symptomsfinishedS
2026-04-21Four-week follow-up: CT angiography results, vascular surgery consultation, and a shared decision about repair thresholdsfinishedS
2026-07-14Three-month review: blood pressure, lipids on a statin, and smoking cessationfinishedS
2026-09-22Six-month aneurysm surveillance with duplex ultrasoundfinishedS
2026-06-02Same-day sick visit for low back pain after liftingfinishedS
2026-08-25Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Aneurysm imaging: duplex ultrasound today and CT angiography within two weeks for baseline anatomy; then duplex ultrasound every six months while the diameter is 5.0 to 5.4 cm, with CT if ultrasound views are poorcompletedGL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022S
Vascular surgery consultation for a shared decision about surveillance, repair thresholds, and the choice between endovascular and open repaircompletedGL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022S
Blood pressure below 130/80: add losartan 50 mg to amlodipine, home blood pressure readings twice daily for a week before each visit, and a metabolic panel two to four weeks after each change, then every six monthscompletedGL-ACCAHA-AORTA-2022, GL-CMID-2026S
Atorvastatin 40 mg each evening, with a baseline ALT and a lipid panel four to twelve weeks after starting, then yearlycompletedGL-ACCAHA-AORTA-2022, GL-SVS-AAA-2018, GL-CMID-2026S
Tobacco cessation: the 5 A's at every visit, a quit date within a week, a 14 mg nicotine patch with 2 mg lozenges for cravings, stepping down over the following months, and the state quitlinecompletedGL-ACCAHA-AORTA-2022, GL-SVS-AAA-2018, GL-USPSTF-TOB-2021S
Emergency plan: sudden severe abdominal, back, flank, or groin pain, fainting, or a tender pulsating lump means calling emergency services at once; carry an aneurysm wallet card; avoid fluoroquinolone antibiotics unless there is no alternativecompletedGL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022S
Low-dose aspirin 81 mg daily for atheroma of the aorta, unless bleeding risk outweighs benefitcompletedGL-ACCAHA-AORTA-2022S
Shared decision on elective repair: repair advised at 5.5 cm by a consistent measurement, growth of 0.5 cm or more in six months, or symptoms from the aneurysm; endovascular repair favored on this anatomy and after a prior laparotomy with wrapping; his preferences reviewed at each scancompletedGL-SVS-AAA-2018, GL-ACCAHA-AORTA-2022S
Monitor on the CMID hypertension and hyperlipidemia schedules: blood pressure and weight at every visit; metabolic panel every six months on losartan; lipids, HbA1c, and urine albumin-to-creatinine ratio yearly; baseline ECG; eye examination yearly; ankle-brachial index every two to three yearscompletedGL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Baseline CT angiography and a vascular surgery consultation, with a documented shared decision about repair thresholds, by the four-week visit2026-04-21completedCT angiography two weeks after the first visit; consultation and shared decision at the four-week visitS
Blood pressure below 130/80 at the clinic and at home by the three-month visit2026-07-14completed126/76 mmHg in the clinic; home average 124/74 on amlodipine 5 mg and losartan 100 mgS
LDL cholesterol at least 50 percent lower and below 70 mg/dL by the three-month visit2026-07-14completedLDL 62 mg/dL on atorvastatin 40 mg, down 56 percent from 142S
Tobacco-free by the three-month visit and still at six months2026-09-22completedNo tobacco since the quit date a week after the first visit; nicotine replacement finished at six monthsS
Repeat duplex ultrasound at six months and set the next interval by diameter2026-09-22completed5.1 cm, 0.1 cm more than at baseline; next scan in six monthsS

Functional Status

Mental Status